Results 11 to 20 of about 97,767 (354)

Destiny

, 2021
Buku kategori novel yang berjudul Destiny merupakan karya dari Eljunwei. Novel Destiny merupakan salah satu dari banyak tulisan yang pernah dibuat oleh penulis, Eljunwei.
Eljunwei, E. (Eljunwei)
core   +2 more sources

Destiny

Gatherings: The Heidegger Circle Annual, 2020
Medium: screenprintMedium: collagraphprintsnot signed, not dated."Destiny" [2021.0004.000.000], Wanambi, WukunArtist and Role: Wanambi, Wukun,Extent ...
Wanambi, Wukun
core   +2 more sources

Inquiry on the Contradictory of Human Free Will and Divine Destiny in Ibn Sina's philosophy [PDF]

Journal of Philosophical Investigations, 2022
Some philosophical-theological conflicts in the topic of A priori science, God's will and omnipotence with the issue of compulsion and human free will are still debated by commentators and experts.
Somayeh Heyran, Abbas Ahmadi Saadi, Mohammad Ali Akhgar   +2 more
doaj   +1 more source

ADHERENCE TO THE ROUTINE NON-PHARMACOLOGIC INTERVENTIONS AMONG PATIENTS WITH CHRONIC ILLNESSES AT A RURAL HEALTH FACILITY SETTING OF UGANDA. A CROSS-SECTIONAL STUDY.

Student's Journal of Health Research Africa, 2023
Background The study aimed at determining the prevalence of adherence to routine non-pharmacological interventions such as counseling, diet and regular physical exercises among patients in a rural health facility setting of Uganda. Methodology:
Irene Nakimera, David Serunjogi
doaj   +1 more source

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Journal of Clinical Oncology, 2023
PURPOSE Trastuzumab deruxtecan (T-DXd) 5.4 and 6.4 mg/kg showed robust antitumor activity in multiple cancer indications; however, T-DXd 5.4 mg/kg has not been evaluated in patients with previously treated human epidermal growth factor receptor 2–mutant (
Koichi Goto, Y. Goto, T. Kubo, K. Ninomiya, Sang-We Kim, D. Planchard, M. Ahn, E. Smit, A. D. de Langen, M. Pérol, E. Pons-Tostivint, S. Novello, H. Hayashi, J. Shimizu, Dong-Wan Kim, C. Kuo, Jie Yang, K. Pereira, Fu-Chih Cheng, Ayumi Taguchi, Yingkai Cheng, Wenqin Feng, Zenta Tsuchihashi, P. Jänne   +23 more
semanticscholar   +1 more source

Antibacterial and Antibiofilm Potency of XF Drugs, Impact of Photodynamic Activation and Synergy With Antibiotics

Frontiers in Cellular and Infection Microbiology, 2022
With increasing incidence of antimicrobial resistance, there is an urgent need for novel and effective antibacterials. Destiny Pharma plc have developed a series of porphyrin-based XF drugs, some with dual mechanisms of antibacterial action.
Emma Louise Board-Davies, William Rhys-Williams, Daniel Hynes, David Williams, Damian Joseph John Farnell, William Love   +5 more
doaj   +1 more source

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Journal of Clinical Oncology, 2023
PURPOSE Trastuzumab deruxtecan (T-DXd) is a human epidermal growth factor 2 (HER2)–directed antibody-drug conjugate approved in HER2-expressing breast and gastric cancers and HER2-mutant non–small-cell lung cancer.
F. Meric-Bernstam, V. Makker, A. Oaknin, Do-Youn Oh, Susana Banerjee, A. González-Martín, K. Jung, I. Ługowska, L. Manso, A. Manzano, B. Melichar, S. Siena, D. Stroyakovskiy, A. Fielding, Yan Ma, S.D. Puvvada, Norah J. Shire, Jung-Yun Lee   +17 more
semanticscholar   +1 more source

Antimicrobial effects of XF drugs against Candida albicans and its biofilms

Frontiers in Fungal Biology, 2023
Compared with antibiotics for treating bacterial infections, there are a limited number of antifungal agents. This is due to several factors, including the difficulties of identifying suitable antifungals that target the fungal cell without damaging host
E. L. Board-Davies, W. Rhys-Williams, D. Hynes, W. G. Love, D. W. Williams   +4 more
doaj   +1 more source

PERSONAL FACTORS RELATED TO ADHERENCE TO THE ROUTINE NON-PHARMACOLOGIC INTERVENTIONS AMONG PATIENTS WITH CHRONIC ILLNESSES ATTENDING LUWEERO HC IV. A CROSS-SECTIONAL STUDY.

Student's Journal of Health Research Africa, 2023
Background The aim of this study is to document the personal factors related to adherence to the routine non-pharmacologic interventions among patients with chronic illnesses attending Luweero HC IV.Non- pharmacological interventions refer to science ...
Irene Nakimera, David Serunjogi
doaj   +1 more source

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.

The Lancet, 2022
BACKGROUND An improvement in progression-free survival was shown with trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer in the progression-free survival interim analysis of the DESTINY-Breast03 ...
S. Hurvitz, R. Hegg, Wei-Pang Chung, S. Im, W. Jacot, V. Ganju, J. Chiu, Bing-he Xu, E. Hamilton, S. Madhusudan, H. Iwata, S. Altıntaş, J. Henning, G. Curigliano, J. Peréz-García, Sung-Bae Kim, V. Petry, Chiun-Sheng Huang, Wei Li, J. Frenel, S. Antolín, W. Yeo, G. Bianchini, S. Loi, J. Tsurutani, A. Egorov, Yali Liu, J. Cathcart, S. Ashfaque, J. Cortés   +29 more
semanticscholar   +1 more source